CN102559932B - 一种高危人乳头瘤病毒的pcr检测试剂盒 - Google Patents
一种高危人乳头瘤病毒的pcr检测试剂盒 Download PDFInfo
- Publication number
- CN102559932B CN102559932B CN 201210016078 CN201210016078A CN102559932B CN 102559932 B CN102559932 B CN 102559932B CN 201210016078 CN201210016078 CN 201210016078 CN 201210016078 A CN201210016078 A CN 201210016078A CN 102559932 B CN102559932 B CN 102559932B
- Authority
- CN
- China
- Prior art keywords
- human papillomavirus
- pcr
- hpv
- kit
- detection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000701806 Human papillomavirus Species 0.000 title claims abstract description 36
- 238000001514 detection method Methods 0.000 title claims abstract description 36
- 238000003752 polymerase chain reaction Methods 0.000 title abstract description 6
- 239000000523 sample Substances 0.000 claims abstract description 57
- 238000003908 quality control method Methods 0.000 claims abstract description 14
- 230000003321 amplification Effects 0.000 claims abstract description 12
- 238000003199 nucleic acid amplification method Methods 0.000 claims abstract description 12
- 238000012360 testing method Methods 0.000 claims description 21
- 238000006243 chemical reaction Methods 0.000 claims description 18
- 108090000790 Enzymes Proteins 0.000 claims description 13
- 102000004190 Enzymes Human genes 0.000 claims description 13
- 239000003153 chemical reaction reagent Substances 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 239000007850 fluorescent dye Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- ABZLKHKQJHEPAX-UHFFFAOYSA-N tetramethylrhodamine Chemical compound C=12C=CC(N(C)C)=CC2=[O+]C2=CC(N(C)C)=CC=C2C=1C1=CC=CC=C1C([O-])=O ABZLKHKQJHEPAX-UHFFFAOYSA-N 0.000 claims description 5
- 238000007400 DNA extraction Methods 0.000 claims description 4
- BFMYDTVEBKDAKJ-UHFFFAOYSA-L disodium;(2',7'-dibromo-3',6'-dioxido-3-oxospiro[2-benzofuran-1,9'-xanthene]-4'-yl)mercury;hydrate Chemical compound O.[Na+].[Na+].O1C(=O)C2=CC=CC=C2C21C1=CC(Br)=C([O-])C([Hg])=C1OC1=C2C=C(Br)C([O-])=C1 BFMYDTVEBKDAKJ-UHFFFAOYSA-L 0.000 claims description 4
- 238000011144 upstream manufacturing Methods 0.000 claims description 4
- AHCYMLUZIRLXAA-SHYZEUOFSA-N Deoxyuridine 5'-triphosphate Chemical compound O1[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C[C@@H]1N1C(=O)NC(=O)C=C1 AHCYMLUZIRLXAA-SHYZEUOFSA-N 0.000 claims description 3
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 claims description 3
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 claims description 3
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 claims description 3
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 abstract description 11
- 230000035945 sensitivity Effects 0.000 abstract description 10
- 238000005516 engineering process Methods 0.000 abstract description 6
- 238000013461 design Methods 0.000 abstract description 5
- 238000009004 PCR Kit Methods 0.000 abstract description 2
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 238000000605 extraction Methods 0.000 abstract description 2
- 102000053602 DNA Human genes 0.000 abstract 2
- 108020004414 DNA Proteins 0.000 abstract 2
- 239000012807 PCR reagent Substances 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 2
- 241001629697 Panicum turgidum Species 0.000 abstract 1
- 101150036080 at gene Proteins 0.000 abstract 1
- 208000022361 Human papillomavirus infectious disease Diseases 0.000 description 40
- 238000000034 method Methods 0.000 description 24
- 239000000047 product Substances 0.000 description 15
- 206010008342 Cervix carcinoma Diseases 0.000 description 12
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 12
- 201000010881 cervical cancer Diseases 0.000 description 12
- 239000012925 reference material Substances 0.000 description 7
- 241000700605 Viruses Species 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 206010028980 Neoplasm Diseases 0.000 description 5
- 239000012634 fragment Substances 0.000 description 5
- 238000009396 hybridization Methods 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 238000012408 PCR amplification Methods 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000009608 Papillomavirus Infections Diseases 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 210000003679 cervix uteri Anatomy 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012452 mother liquor Substances 0.000 description 3
- 230000007170 pathology Effects 0.000 description 3
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000341655 Human papillomavirus type 16 Species 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- 108091034117 Oligonucleotide Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000002547 anomalous effect Effects 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 238000001493 electron microscopy Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 2
- 238000002866 fluorescence resonance energy transfer Methods 0.000 description 2
- 238000012151 immunohistochemical method Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 238000003753 real-time PCR Methods 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 108091008146 restriction endonucleases Proteins 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- 101150047313 52 gene Proteins 0.000 description 1
- 101150060295 58 gene Proteins 0.000 description 1
- 206010059313 Anogenital warts Diseases 0.000 description 1
- 206010062317 Condyloma latum Diseases 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 208000009849 Female Genital Neoplasms Diseases 0.000 description 1
- 108020004711 Nucleic Acid Probes Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 241001631646 Papillomaviridae Species 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N ferric oxide Chemical compound O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 208000020082 intraepithelial neoplasia Diseases 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000002853 nucleic acid probe Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 238000011897 real-time detection Methods 0.000 description 1
- 210000005000 reproductive tract Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000001018 virulence Effects 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
Images
Landscapes
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
引物名称 | 序列 |
H1(SEQ ID NO:1) | 5’-TGGCATAACCAACTATTTGTTA-3’ |
H2(SEQ ID NO:2) | 5’-TAAACTGTAAATCATATTCCTC-3’ |
探针名称 | 序列 |
H3(SEQ ID NO:3) | 5’-FAM-CTGCCATATCTACTTCAGAA-TAMRA-3’ |
H4(SEQ ID NO:4) | 5’-FAM-CACAGTCTCCTGTACCTGGGCA-TAMRA-3’ |
H5(SEQ ID NO:5) | 5’-FAM-ACTAGTGACAGTACATATAAAAAT-TAMRA-3’ |
H6(SEQ ID NO:6) | 5’-FAM-CACTCGTAGCACTAACATGACTTT-TAMRA-3’ |
H7(SEQ ID NO:7) | 5’-FAM-ATATGACATTATGCACTGAAGTAA-TAMRA-3’ |
试剂 | (μL) |
纯水 | 22.5 |
10×PCR buffer | 5 |
25mM MgCl2 | 8 |
dN(U)TP(20、40mM) | 0.5 |
10μM H1 | 1.5 |
10μM H2 | 1.5 |
10μM H3 | 1 |
10μM H4 | 1 |
10μM H5 | 1 |
10μM H6 | 1 |
10μM H7 | 1 |
At-Taq酶/UNG酶系 | 1 |
总量 | 45 |
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210016078 CN102559932B (zh) | 2012-01-18 | 2012-01-18 | 一种高危人乳头瘤病毒的pcr检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201210016078 CN102559932B (zh) | 2012-01-18 | 2012-01-18 | 一种高危人乳头瘤病毒的pcr检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102559932A CN102559932A (zh) | 2012-07-11 |
CN102559932B true CN102559932B (zh) | 2013-07-03 |
Family
ID=46406531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201210016078 Active CN102559932B (zh) | 2012-01-18 | 2012-01-18 | 一种高危人乳头瘤病毒的pcr检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102559932B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104651531B (zh) * | 2015-01-24 | 2017-03-22 | 中国农业科学院兰州兽医研究所 | 用于检测青少年复发性呼吸道乳头瘤状病毒的试剂盒 |
CN109402297A (zh) * | 2018-11-05 | 2019-03-01 | 泰普生物科学(中国)有限公司 | 单管检测15种hpv基因型的试剂盒及方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101217976A (zh) * | 2005-04-26 | 2008-07-09 | 葛兰素史密丝克莱恩生物有限公司 | 疫苗 |
WO2007066831A2 (en) * | 2005-12-08 | 2007-06-14 | Kabushiki Kaisha Toshiba | Method of detecting human papilloma virus by using nucleic acid amplification method and nucleic acid chain-immobilized carrier |
CN101464456B (zh) * | 2007-12-20 | 2013-06-12 | 北京金菩嘉医疗科技有限公司 | 用表面等离子共振技术检测病毒的方法以及其中使用的芯片 |
-
2012
- 2012-01-18 CN CN 201210016078 patent/CN102559932B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN102559932A (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103642945B (zh) | 一种含内参照的高灵敏Epstein-Barr病毒荧光定量PCR试剂盒 | |
CN105755169B (zh) | 一种高危型人乳头瘤病毒的检测和分型试剂盒及其应用 | |
CN107177699A (zh) | 一种人类乳头瘤病毒(hpv)分型快速检测方法 | |
CN102251056A (zh) | 人类乳头瘤病毒核酸基因扩增和分型的方法以及用于该方法的检测试剂盒 | |
CN104017907B (zh) | 一种hpv高危型荧光pcr检测试剂盒 | |
CN110628953B (zh) | 一种用于人乳头瘤病毒分型检测的试剂盒 | |
CN106868227A (zh) | 基于恒温隔绝式荧光pcr平台的牦牛轮状病毒检测试剂盒及应用 | |
CN104017906B (zh) | 一种hpv高危型分型荧光pcr检测试剂盒 | |
CN105018647B (zh) | 一种基于数字pcr精准定量分型检测hpv16/18的试剂盒及其检测方法 | |
CN102229930B (zh) | 人乳头瘤病毒检测试剂盒 | |
CN105385786B (zh) | 一种人乳头瘤病毒荧光定量pcr检测试剂盒及其使用方法 | |
CN106148484B (zh) | 一种诊断y染色体微缺失的试剂盒 | |
CN103725794A (zh) | 检测prrsv的荧光定量rt-pcr引物、探针及其方法 | |
CN103074428B (zh) | 一种结核分枝杆菌tb检测试剂盒 | |
CN101503741A (zh) | 用于检测高危型人乳头瘤病毒的试剂盒及其制备和应用 | |
CN102559932B (zh) | 一种高危人乳头瘤病毒的pcr检测试剂盒 | |
CN105950788B (zh) | 检测18种高危型hpv核酸的引物、探针及试剂盒 | |
CN105274100A (zh) | 人TWIST1/Vimentin基因甲基化检测标志物及试剂盒 | |
CN112813195A (zh) | 基于微液滴数字分析的新型冠状病毒核酸定量检测试剂盒 | |
CN101886137A (zh) | 荧光定量pcr定性检测高危型hpv的方法及其试剂盒 | |
CN103290141A (zh) | 16种高危型和5种低危型hpv检测试剂盒 | |
WO2020134950A1 (zh) | 用于肺结节良恶性鉴别的基因突变/融合组合及试剂盒 | |
CN103114132B (zh) | 一种用于检测宫颈癌致癌基因的引物探针、试剂盒及用于非检测疾病目的的检测方法 | |
CN103122395A (zh) | 高危型人乳头瘤病毒hpv16/18检测试剂盒 | |
CN104293974A (zh) | 人乳头瘤病毒核酸检测方法和试剂盒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TRIPLEX INTERNATIONAL BIOSCIENCES CO., LTD. Free format text: FORMER OWNER: TRIPLEX INTERNAT BIOSCIENCES (CHINA) CO., LTD. Effective date: 20150210 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150210 Address after: 350002, No. 7, No. two, No. 7, Jinzhou North Road, Jinshan Industrial Zone, Fujian, Fuzhou, four floors Patentee after: TRIPLEX INTERNATIONAL BIOSCIENCES Co.,Ltd. Address before: 350002, No. 7, No. two, No. 7, Jinzhou North Road, Jinshan Industrial Zone, Fujian, Fuzhou, four floors Patentee before: TRIPLEX INTERNATIONAL BIOSCIENCES (CHINA) Co.,Ltd. |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20220411 Granted publication date: 20130703 |
|
PD01 | Discharge of preservation of patent |
Date of cancellation: 20240123 Granted publication date: 20130703 |
|
PD01 | Discharge of preservation of patent |